Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

20.87 -0.78 (-3.60%)
Streaming Delayed Price Updated: 2:41 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 212 companies made new 52-week lows. 
Via Benzinga
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond.
These stocks have moved in opposite directions lately, but both could deliver solid returns to patient investors. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 221 companies hit new 52-week lows. 
Via Benzinga
8 Analysts Have This to Say About Tandem Diabetes Care
Via Benzinga
Tandem Diabetes Care to Present at the Jefferies Healthcare Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 63 companies hit new 52-week lows. 
Via Benzinga
Why Tandem Diabetes Care Shares Are Falling Today
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares are down Thursday morning as its Q1 results missed Street expectations. 
Via Benzinga
2 Beaten-Down Growth Stocks to Buy in April
These companies have lucrative opportunities ahead. 
Via The Motley Fool
Where Tandem Diabetes Care Stands With Analysts
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Tuesday, 164 companies hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023
Via Benzinga
2 Growth Stocks to Buy While They Are Still Down
Don't wait too long before loading up on these stocks. 
Via The Motley Fool
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Pressured As Control-IQ Trials Combined; Raymond James Downgrades TNDM
Tandem Diabetes Care (NASDAQ: TNDM) remained under pressure on Monday, after the company accounted for plans of a combined analysis of three tri 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
Via Benzinga
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
From Tandem Diabetes Care, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
This Stock Could Soar By as Much as 106%, According to Wall Street
Some of Wall Street's predictions seem a bit aggressive, but investors should still consider this company. 
Via The Motley Fool
Tandem Diabetes Care Shares Fell Post Q4 Results; Guides Within Estimates
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Tandem Diabetes Care Appoints New Chair of Board of Directors
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
Via Benzinga
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback